Pavlo Kot

Flu and COVID-19 vaccine impact on children under review by Veradigm

Flu and COVID-19 vaccine impact on children under review by Veradigm
Veradigm studies child vaccines

Veradigm presented research comparing the effectiveness of receiving flu and COVID-19 vaccines together for children in the U.S.

The results were shared at the #ISPOREurope2026 conference and focus on vaccine outcomes among pediatric populations. No additional data or specific findings were disclosed in the company announcement.

Veradigm previously presented research on testing and evaluation gaps before testicular cancer diagnosis in young men at ISPOREU2026. The company has also earned HITRUST i1 certification for 16 solutions, including EHR and ePrescribe, reflecting a focus on healthcare data security and compliance earlier this year. These developments come as Veradigm continues to share new studies on pediatric and young adult healthcare outcomes.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.